Claudio Salvagnini has many years of experience in the fine chemicals and pharmaceutical industry in commercial, business development, marketing and M&A roles. In the Polpharma API Business Unit he is responsible for the CDMO market.
Karol Sągol is Technology Development Team Manager in Technological Development Department. He defended his Master at University of Gdańsk in the field of biological chemistry. For over 12 years Karol is involved at Polpharma in many projects related to crystallization process of the active substances and is responsible for both development of polymorphic form as well as troubleshooting of production processes.
Adam Hałuszczuk is an experienced organoselenium chemist with many years of experience in organic synthesis. He is pursuing his PhD at the Gdańsk University of Technology in the field of selenium chemistry. He is involved in the development and optimization of many processes at Polpharma and is directly engaged in developing an approach to nitrosamine impurities in Polpharma API BU.
Thank you for your interest in our webinars. Please complete the following spaces. After registration, you will be redirected to the materials page.